News Daily News Frail Older Patients With AF May Fare Better Switching to DOAC Todd Neale August 05, 2025
News Daily News Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures Todd Neale June 10, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI Michael O'Riordan April 02, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools Todd Neale March 19, 2025
News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis Yael L. Maxwell February 27, 2025
News Conference News STS 2025 Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival Yael L. Maxwell January 27, 2025
News Daily News Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3 Yael L. Maxwell January 15, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2024 Shelley Wood December 03, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Daily News IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC Michael O'Riordan November 11, 2024
News Conference News ESC 2024 Asundexian for AF? More Details on the Sinking of OCEANIC-AF Shelley Wood September 02, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea Todd Neale August 27, 2024
News Daily News Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis Todd Neale July 12, 2024